Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients

机译：严重的肾脏损伤作为新诊断的多发性骨髓瘤患者生存的不良预后因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Renal impairment (RI) is associated with poor survival in newly diagnosed multiple myeloma (MM) patients. Renal function recovery has been one of the main therapeutic goals in those patients.

著录项

期刊名称 Journal of Clinical Laboratory Analysis
作者
Xuduan Chen; Xiaofeng Luo; Yanping Zu; Hajji Ally Issa; Linlin Li; Hong Ye; Ting Yang; Jianda Hu; Lixin Wei;
展开▼
作者单位

展开▼
年(卷),期 2020(34),9
年度 2020
页码 e23416
总页数 8
原文格式 PDF
正文语种
中图分类生理学;
关键词
bortezomib; multiple myeloma; overall survival; renal impairment; renal response;

机译：Bortezomib;多发性骨髓瘤;整体存活;肾损伤;肾反应;

相似文献

外文文献
中文文献
专利

1. Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients [J] . Xuduan Chen, Xiaofeng Luo, Yanping Zu, Journal of clinical laboratory analysis. . 2020,第9期

机译：严重的肾脏损伤作为新诊断的多发性骨髓瘤患者生存的不良预后因素
2. Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study [J] . Runzhe Chen, Xiaoping Zhang, Chong Gao, Cancer Management and Research . 2017,第2期

机译：新诊断的硼替佐米和地塞米松方案治疗的多发性骨髓瘤患者生存率的治疗和预后因素：单项中国中心回顾性研究
3. Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report [J] . Wu Tao, Zhou Jinmao, Wang Cunbang, Oncology letters . 2017,第6aPta2期

机译：Bortezomib克服了肾损伤在具有多个骨髓瘤的新诊断的老年患者中的负面预后影响：案例报告
4. Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements [C] . Pu Yonglin, Baad Michael J., Jiang Yulei, International Joint Conference on Neural Networks . 2014

机译：人工神经网络和多元线性回归模型在包括FDG-PET测量在内的多种预后因素预测非小细胞癌患者生存时间中的应用
5. Mutation, SNP and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients. [D] . Onwuazor, Obiageli Nneka. 2003

机译：150名新诊断的多发性骨髓瘤患者的成纤维细胞生长因子受体3（FGFR3）的突变，SNP和同工型分析。
6. Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma [O] . R Khan, S Apewokin, M Grazziutti, -1

机译：尽管新诊断的多发性骨髓瘤全面治疗后肾功能改善但肾功能不全仍保留不良预后影响
7. Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report [O] . Tao Wu, Jinmao Zhou, Cunbang Wang, 2017

机译：Bortezomib克服了肾脏损伤在具有多个骨髓瘤的新诊断的老年患者中的负面预后影响：案例报告

Severe renal impairment as an adverse prognostic factor for survival in newly diagnosed multiple myeloma patients

摘要

著录项

相似文献

相关主题

期刊订阅